LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

It is used to restore and maintain blood volume in patients with a reduction in circulating blood volume, when deemed necessary by a physician.

Dosage form: solution for infusion

ATC: B05AA01

It is used in adults and adolescents (from 12 years of age and older) born with hemophilia A or B who have developed inhibitors (antibodies), to treat bleeding episodes and to manage bleeding during surgical procedures.

Dosage form: solution for injection, powder and solvent

ATC: B02BD08

It is used to compensate for human fibrinogen deficiency and to prevent or treat bleeding in people with congenital fibrinogen deficiency (a hereditary disease that causes prolonged bleeding).

Dosage form: solution for injection/infusion, powder and solvent for preparation of

ATC: B02BB01

This medicinal product contains human antibodies and is used for two main purposes: as replacement therapy for those who do not have enough antibodies (due to congenital or acquired problems) and for the treatment of certain inflammatory diseases, such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, and certain neuropathies.

Dosage form: solution for infusion

ATC: J06BA02

It is used to prevent and treat bleeding during surgical procedures or other types of bleeding in people with von Willebrand disease, when treatment with desmopressin is ineffective or cannot be used.

Dosage form: powder for preparation of injectable suspension

ATC: B02BD10